Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Johnson & Johnson : Morgan Stanley Downgrades Johnson & Johnson to Equalweight from Overweight, Keeps $187 Price Target

09/07/2021 | 09:26am EDT


© MT Newswires 2021
All news about JOHNSON & JOHNSON
05:03pUS Stocks Extend Winning Streak as Factory Output Posts Surprise Drop
MT
04:45pCLOSE UPDATE : US Stocks Start Week Mostly Higher Ahead of Next Earnings Batch Even as Fac..
MT
10:36aToday on Wall Street: This is the real test
08:12aJOHNSON & JOHNSON : 17 Million Doses of Johnson & Johnson COVID-19 Vaccine to be Donated t..
PU
04:25aJOHNSON & JOHNSON : The Janssen Pharmaceutical Companies - OPSYNVI (macitentan and tadalaf..
AQ
04:25aJOHNSON & JOHNSON : COVID-19 Vaccine Booster Shot Unanimously Recommended for Emergency Us..
AQ
12:42aGENMAB A/S : Janssen Receive Positive Opinion for Lung Cancer Treatment from EU Committee
MT
12:23aCORRECTION : US FDA Panel Backs Second Dose of Johnson & Johnson's COVID-19 Jab
MT
12:11aJOHNSON & JOHNSON : US FDA Panel Backs Second Dose of Johson & Johnson's COVID-19 Jab
MT
10/15S&P 500 Posts 1.8% Weekly Gain, Strongest Since July, Amid Positive Start to Q3 Results..
MT
More news
Analyst Recommendations on JOHNSON & JOHNSON
More recommendations
Financials (USD)
Sales 2021 93 970 M - -
Net income 2021 22 809 M - -
Net cash 2021 2 466 M - -
P/E ratio 2021 18,5x
Yield 2021 2,60%
Capitalization 422 B 422 B -
EV / Sales 2021 4,46x
EV / Sales 2022 4,18x
Nbr of Employees 134 500
Free-Float 84,3%
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | MarketScreener
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 160,12 $
Average target price 185,83 $
Spread / Average Target 16,1%
EPS Revisions
Managers and Directors
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capi. (M$)
JOHNSON & JOHNSON2.49%424 619
ROCHE HOLDING AG16.59%339 442
NOVO NORDISK A/S54.22%234 792
PFIZER, INC.12.71%232 621
ELI LILLY AND COMPANY40.89%215 657
MERCK & CO., INC.-4.24%198 283